HealthQuill US
About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave of the Covid-19 pandemic, according to a study.
Drugs Health Pharma

Antimalarial drug may have killed 17,000 people in first Covid-19 wave

HQ Team January 8, 2024: About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave.

Read More
The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared to two weeks prior, according to the National Public Health Agency.
Drugs Health Pharma

JN.1 sub-variant Covid-19 cases rise to 62% in the US, says CDC 

HQ Team January 8, 2023: The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared.

Read More
More than 50 million people in the US experience an allergic reaction every year. They are the sixth leading cause of long-term illness in that country. In India allergies are a growing concern and about 20-30% of the population suffer from at least one allergic disease.
Drugs Health Pharma

Opinion: Curb calls, use earbuds, dump old mobile phones to fight allergens

By Dr K. Leelamoni January 3, 2024: I started fretting a month ago when my friend Radhika stopped answering my cellphone calls. She.

Read More
Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to treat nervous system impairment.
Drugs Health Pharma

USFDA clears AstraZeneca-Ionis’ drug for nervous system impairment

HQ Team December 22, 2023: Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to.

Read More
A new vaccine to aid the human body's white cells to fight HIV infection may hold the key to protect people from acquiring the virus, according to a National Institute of Allergic and Infectious Diseases (NIAID) study.
Drugs Health Pharma

New HIV vaccine must aid human white cells to ward off virus: NIAID

HQ Team December 15, 2023: A new vaccine to aid the human body’s white cells to fight HIV infection may hold the key.

Read More
Japan’s Eisai Co., and US-based Biogen Inc., announced its Leqembi injection will be sold in Japan from Japan from December 20, the second country after the US.
Drugs Health Pharma

Eisai, Biogen to sell Alzheimer’s drug in Japan starting December 20 

HQ Team December 13, 2023: Japan’s Eisai Co., and US-based Biogen Inc., announced its Leqembi injection will be sold in Japan from Japan.

Read More
Australian researchers reveal that having a cat can potentially double a person’s risk of schizophrenia-related disorders transmitted through a parasite found in the animals.
Drugs Health Pharma

Exposure to a parasite found in cats may double risk of schizophrenia

HQ Team December 11, 2023: Australian researchers reveal that having a cat can potentially double a person’s risk of schizophrenia-related disorders transmitted through.

Read More
Rocky Mountain spotted fever is spread to people through bites by wood ticks or dog ticks. In Brazil, it may be spread by the yellow dog tick. Image courtesy of Dr. Christopher Paddock via the Public Health Image Library of the Centers for Disease Control and Prevention.
Drugs Health Pharma

CDC issues health advisory on Rocky Mountain spotted fever, 3 die

HQ Team December 9, 2023: The Centers for Disease Control and Prevention (CDC) has issued a health advisory after three people died following.

Read More
Pneumonia is a form of acute respiratory infection that affects the lungs and kills more children than any other infectious disease. Every day at least one child dies from pneumonia every 43 seconds, according to UNICEF.
Drugs Health Pharma

Opinion: Steps for prevention, spread, and monitoring pneumonia

By K. Leelamoni November 5, 2023: Outbreaks of pneumonia affecting children in parts of northern China, the US,  the Netherlands, and Denmark are higher than.

Read More
The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global health agency reported an 8.9% rise in global prevalence in cases arising in the UK, France and Sweden.
Drugs Health Pharma

Omicron mutant BA.2.86 reclassified as ‘variant of interest’ by WHO 

HQ Team November 29, 2023: The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global.

Read More